The Wedding Bells Sound Really Good! iGlarLixi Fixed-Ratio Combination in the Treatment of Type 2 Diabetes: A Narrative Review

iGlarLixi is a fixed-ratio combination of insulin glargine 100 U/mL and lixisenatide used in the treatment of type 2 diabetes. iGlarLixi has proven clinical benefits in terms of glycemia, weight control, and safety, defined by the risk of hypoglycemia. It simultaneously targets many pathophysiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwiendacz, Hanna, Nabrdalik, Katarzyna, Czupryniak, Leszek, Klupa, Tomasz, Małecki, Maciej, Myśliwiec, Małgorzata, Strojek, Krzysztof, Gumprecht, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329951/
https://www.ncbi.nlm.nih.gov/pubmed/37326901
http://dx.doi.org/10.1007/s12325-023-02567-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329951/
https://www.ncbi.nlm.nih.gov/pubmed/37326901
http://dx.doi.org/10.1007/s12325-023-02567-1

Ejemplares similares